Skip to main content
. 2016 Jul 22;5(1):1151. doi: 10.1186/s40064-016-2819-8

Fig. 3.

Fig. 3

Network diagrams for incidence of any adverse events (a), any serious adverse events (b), and any treatment-related adverse events (c) at 12 weeks. AZA azelaic acid, bid twice daily, IVE ivermectin, MET metronidazole, OD once daily. Note: network diagrams for the incidence of burning/stinging, skin irritation, worsening of erythema, and worsening of rosacea at 12 weeks are available in the Additional file 1